PTC Therapeutics | PTCT - Attività Correnti





Attività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amgen USD 34.36B 598M 2026-09
BioCryst Pharmaceuticals USD 531.15M 46.47M 2026-09
Biogen USD 7.58B 278.7M 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Cytokinetics USD 1.19B 21.34M 2026-09
Daiichi Sankyo JPY 2.38T 150.33B 2026-09
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Gilead Sciences USD 16.55B 4.02B 2026-09
Incyte USD 5.52B 505.2M 2026-09
Ionis Pharmaceuticals USD 2.36B 129.77M 2026-09
Ironwood Pharmaceuticals USD 225.99M 26.79M 2026-09
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Novartis USD 28.75B 1.4B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Puma Biotechnology USD 143.58M 7M 2025-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
TG Therapeutics USD 1.17B 25.76M 2026-09
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09
Xencor USD 498.66M 24.55M 2026-09